Definitive Contract 75F40124C00124
Award Date
9/19/24
Potential Completion Date
9/29/26
Potential Value
$1.6M
Federal Agency
Food and Drug Administration
Ultimate Awardee
Not listed
PSC Category
AJ11 - General Science And Technology R&D Services; General Science And Technology; Basic Research
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Manchester, NH 03101, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $29,266,207.99 firm fixed price contract awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Advanced Regenerative Manufacturing Institute Inc. (Armi), a non-profit organization. The contract aims to establish the Foundry for American Biotechnology (NEXTFAB) to accelerate research, development, manufacturing, and deployment of revolutionary advances in science to support pandemic preparedness and...
This federal contract award, valued at $300,000.00, was issued by the Department of Health and Human Services Food and Drug Administration to the National Center For Defense Manufacturing And Machining, a non-profit organization, for a COVID-19 impact survey of interagency 3D printing response efforts. The contract has a completion date of April 30, 2021 and is classified as a Firm Fixed Price Purchase Order with no set-aside designation. The National Center For Defense Manufacturing And...
The Department of Health and Human Services Food and Drug Administration awarded a definitive contract valued at $82.2 million to the Massachusetts Institute of Technology under Broad Agency Announcement FY22 FDA BAA for Advanced Research and Development of Regulatory Science. The contract supports the development of an integrated continuous cGMP facility for mRNA manufacturing to address the solicitation's goal of advancing regulatory science tools and approaches for safety and quality...
The Department of Health and Human Services' Biomedical Advanced Research and Development Authority awarded a $269,952,453 firm fixed price definitive contract to Global Health Investment Corporation, a nonprofit organization. This contract establishes a public-private partnership through BARDA's other transaction authority to address gaps in pandemic preparedness and response. Specifically, the partnership will foster and accelerate medical countermeasure development using strategic venture...
<p>This is a $11,000,000.00 definitive contract awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Deka Research & Development Corp, a for-profit Subchapter S Corporation. The contract is for advanced research on a distributed intravenous (IV) solution, with a completion date of August 14, 2020. The contract is a firm fixed price arrangement and was not set aside for any particular business type.</p>
This federal contract award, valued at $55,262,789.30, was issued by the Defense Health Agency to the Medical Technology Enterprise Consortium (MTEC), a nonprofit organization that serves as a medical technology accelerator for the Department of Defense. The contract, which has no set-aside designation, is for a research project titled "Armed Forces Institute for Regenerative Medicine." The contract utilizes an Other Transaction Order contract type, which provides flexible mechanisms...
This is a $4,091,483.00 Firm Fixed Price contract awarded by the National Institutes of Health (NIH) to Feromics Inc., a small business located in Brookline, MA. The contract is for research and development (R&D) projects that will advance the mission and objectives of the Advanced Research Projects Agency for Health (ARPA-H) and the Small Business Innovation Research (SBIR) program. The contract covers six specific topic areas relating to affordable viral vector manufacturing, lymphatic...
This is a $65,806,649.98 cost-plus-fixed-fee contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to Biofactura Inc. for preclinical and manufacturing development activities. The contract includes cell line development, process development, non-clinical efficacy and safety studies, manufacturing, and clinical activities. The contract was awarded on September 26, 2019 with an ultimate completion date of March 30, 2029. The contract has no...
The U.S. Department of Health and Human Services (HHS), through the National Institute of Allergy and Infectious Diseases (NIAID), awarded a $14,104,415.00 cost-no-fee contract to Beth Israel Deaconess Medical Center, Inc. (BIDMC) for the "DEVELOPMENT OF IMMUNE MONITORING REAGENTS AND MHC TYPING TECHNOLOGIES". This definitive contract, awarded on September 30, 2004, has an ultimate completion date of September 29, 2009. BIDMC, a non-profit academic medical center and teaching...
This is a $95,657,577.18 cost-plus-fixed-fee definitive contract awarded by the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response to Arteriocyte, Inc. (doing business as Compass Biomedical) for "BIO-BANDAGE" products and related functions. The contract has a performance period ending on May 15, 2019 and was initially awarded on September 16, 2013. This contract is not designated as a set-aside procurement. The Office of the...